Request Free Sample
×
India Allergy Immunotherapy Market
ID: MRFR/HC/54531-HCR
200 Pages
February 2026
India Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies) andBy Patient Type (Pediatric, Adult, Geriatric)- Forecast to 2035
Industry Developments
The India Allergy Immunotherapy Market has seen several significant developments recently. In July 2023, Merck launched a new allergy immunotherapy product aimed at enhancing treatment options for allergic rhinitis, targeting a growing patient population. Additionally, in September 2023, Stallergenes Greer announced a collaboration with local clinics in India to increase awareness and accessibility of their sublingual immunotherapy products. The market landscape is further shaped by the entry of Aimmune Therapeutics and UCB, which have introduced innovative therapies catering to food allergies. In terms of mergers and acquisitions, Regeneron Pharmaceuticals completed an acquisition of a biotechnology firm specializing in allergic diseases in June 2023, reinforcing its commitment to advancing treatments in this field. The overall growth in the allergy immunotherapy market in India is impacted by increasing allergic conditions, with a reported market valuation of over USD 600 million as of early 2023, driven by heightened awareness and demand for effective long-term solutions. Noteworthy trends include a rise in research initiatives focusing on personalized medicine and the integration of digital health solutions to improve patient management in allergy therapies.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 212.8(USD Million) |
| MARKET SIZE 2024 | 228.4(USD Million) |
| MARKET SIZE 2035 | 914.8(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.445% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Merck, Stallergenes Greer, S interrogative S A, Aimmune Therapeutics, UCB, Boehringer Ingelheim, Regeneron Pharmaceuticals, Novartis, Sheller S.A., Vaccine Technologies, Diater, ImmunoCAP, Allergan |
| SEGMENTS COVERED | Type, Product, Indication, Patient Type |
| KEY MARKET OPPORTUNITIES | Rising allergic disease prevalence, Increasing disposable income, Growing awareness of immunotherapy, Expansion of healthcare infrastructure, Enhanced regulatory support for therapies |
| KEY MARKET DYNAMICS | rising allergy prevalence, increasing awareness, supportive government policies, technological advancements, growing healthcare expenditure |
| COUNTRIES COVERED | India |
Leave a Comment
FAQs
What is the expected market size of the India Allergy Immunotherapy Market in 2024?
The India Allergy Immunotherapy Market is expected to be valued at 228.4 million USD in 2024.
What will be the market value of the India Allergy Immunotherapy Market by 2035?
By 2035, the India Allergy Immunotherapy Market is projected to reach 914.8 million USD.
What is the expected CAGR for the India Allergy Immunotherapy Market from 2025 to 2035?
The expected compound annual growth rate (CAGR) for the India Allergy Immunotherapy Market is 13.445% from 2025 to 2035.
Which type of immunotherapy is anticipated to dominate the market in 2024?
Subcutaneous Immunotherapy is anticipated to dominate the market with a value of 91.4 million USD in 2024.
How much revenue is Sublingual Immunotherapy expected to generate in 2035?
Sublingual Immunotherapy is expected to generate 276.4 million USD in revenue by 2035.
What are the major players in the India Allergy Immunotherapy Market?
Major players in the market include Merck, Stallergenes Greer, Aimmune Therapeutics, and Novartis.
What will be the market value of Oral Immunotherapy in 2024?
Oral Immunotherapy is valued at 69.4 million USD in the India Allergy Immunotherapy Market for 2024.
What growth opportunities exist for new entrants in the India Allergy Immunotherapy Market?
Rapidly growing awareness and increasing prevalence of allergies present significant growth opportunities for new entrants in the market.
How will the market growth rate differ among segments by 2035?
By 2035, the growth rate is expected to be highest in Subcutaneous Immunotherapy, reaching 370.5 million USD.
What challenges does the India Allergy Immunotherapy Market currently face?
Challenges include regulatory hurdles and the need for advanced technology in the production of immunotherapy solutions.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense